1 General Purpose
In pharmaceutical research and
development, multiple factors like age, gender, comorbidity,
concomitant medication, genetic and environmental factors
co-determine the efficacy of the new treatment. In statistical
terms we say, they interact with the treatment efficacy.
Interaction is different from
confounding. In a trial with interaction effects the parallel
groups have similar characteristics. However, there are subsets of
patients that have an unusually high or low response.

The above figure shows the essence of
interaction: the males perform better than the females with the new
medicine, with the control treatment the opposite (or no difference
between males and females) is true.
2 Schematic Overview of Type of Data File

3 Primary Scientific Question
Are there not only independent effects
of two predictors on the outcome, but also interaction effects
between two predictors on the outcome.
4 Data Example
In a 40 patient parallel-group study of
the effect of verapamil and metoprolol on paroxysmal atrial
fibrillation (PAF) the possibility of interaction between gender
and treatment on the outcome was assessed. The numbers of episodes
of paroxysmal atrial tachycardias per patient, are the outcome
variable. The entire data file is in extras.springer.com, and is
entitled “chapter23interaction”. The first ten patients of the data
file is given below.
PAF
|
Treat
|
Gender
|
52,00
|
,00
|
,00
|
48,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
50,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
44,00
|
,00
|
,00
|
46,00
|
,00
|
,00
|
46,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
49,00
|
,00
|
,00
|
5 Data Summaries
Verapamil
|
Metoprolol
|
|
Males
|
||
52
|
28
|
|
48
|
35
|
|
43
|
34
|
|
50
|
32
|
|
43
|
34
|
|
44
|
27
|
|
46
|
31
|
|
46
|
27
|
|
43
|
29
|
|
49 +
|
25 +
|
|
464
|
302
|
766
|
Females
|
||
38
|
43
|
|
42
|
34
|
|
42
|
33
|
|
35
|
42
|
|
33
|
41
|
|
38
|
37
|
|
39
|
37
|
|
34
|
40
|
|
33
|
36
|
|
34 +
|
35 +
|
|
368
|
378
|
746
|
832
|
680
|
Overall, metoprolol seems to perform
better. However, this is only true for one subgroup (males). The
presence of interaction between gender and treatment modality can
be assessed several ways: (1) t-tests (see Chapter 18, Statistics
on a pocket calculator part one, Springer New York, 2011, from the
same authors), (2) analysis of variance, and (3) regression
analysis. The data file is given underneath.
6 Analysis of Variance
We will first perform an analysis of
variance. Open the data file in SPSS.
For analysis the General Linear Model
is required. It consists of four statistical models:
-
Univariate,
-
Multivariate,
-
Repeated Measures,
-
Variance Components.
We will use here Univariate.
Command:
-
Analyze….General Linear Model….Univariate Analysis of Variance …. Dependent: PAF….Fixed factors:treatment, gender….click OK.
Tests of Between-Subjects Effects
Dependent Variable: outcome
Source
|
Type III sum of squares
|
df
|
Mean square
|
F
|
Sig.
|
---|---|---|---|---|---|
Corrected model
|
1327,200a
|
3
|
442,400
|
37,633
|
,000
|
Intercept
|
57153,600
|
1
|
57153,600
|
4861,837
|
,000
|
Treatment
|
577,600
|
1
|
577,600
|
49,134
|
,000
|
Gender
|
10,000
|
1
|
10,000
|
,851
|
,363
|
Treatment * gender
|
739,600
|
1
|
739,600
|
62,915
|
,000
|
Error
|
423,200
|
36
|
11,756
|
||
Total
|
58904,000
|
40
|
|||
Corrected total
|
1750,400
|
39
|
The above table shows that there is a
significant interaction between gender and treatment at p = 0,0001
(* is sign of multiplication). In spite of this, the treatment
modality is a significant predictor of the outcome. In situations
like this it is often better to use a socalled random effect model. The “sum of
squares treatment” is, then, compared to the “sum of squares
interaction” instead of the “sum of squares error”. This is a good
idea, since the interaction was unexpected, and is a major
contributor to the error, otherwise called spread, in the data.
This would mean, that we have much more spread in the data than
expected, and we will lose a lot of power to prove whether or not
the treatment is a significant predictor of the outcome, episodes
of PAF. Random effect analysis of variance requires the following
commands:
Command:
-
Analyze….General Linear Model….Univariate Analysis of Variance …. Dependent: PAF….Fixed Factors: treatment…. Random Factors: gender….click OK
The underneath table shows the
results. As expected the interaction effect remained statistically
significant, but the treatment effect has now lost its
significance. This is realistic, since in a trial with major
interactions, an overall treatment effect analysis is not relevant
anymore. A better approach will be a separate analysis of the
treatment effect in the subgroups that caused the interaction.
Tests of between-subjects effects
Dependent Variable:outcome
Source
|
Type III sum of squares
|
df
|
Mean square
|
F
|
Sig.
|
|
---|---|---|---|---|---|---|
Intercept
|
Hypothesis
|
57153,600
|
1
|
57153,600
|
5715,360
|
,008
|
Error
|
10,000
|
1
|
10,000a
|
|||
Treatment
|
Hypothesis
|
577,600
|
1
|
577,600
|
,781
|
,539
|
Error
|
739,600
|
1
|
739,600b
|
|||
Gender
|
Hypothesis
|
10,000
|
1
|
10,000
|
,014
|
,926
|
Error
|
739,600
|
1
|
739,600b
|
|||
Treatment * gender
|
Hypothesis
|
739,600
|
1
|
739,600
|
62,915
|
,000
|
Error
|
423,200
|
36
|
11,756c
|
As a contrast test we may use
regression analysis for these data. For that purpose we first have
to add an interaction variable:
-
interaction variable = treatment modality * gender
-
(* = sign of multiplication).
Underneath the first 10 patients of
the above data example is given, now including the interaction
variable.
PAF
|
Treat
|
Gender
|
Interaction
|
52,00
|
,00
|
,00
|
,00
|
48,00
|
,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
,00
|
50,00
|
,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
,00
|
44,00
|
,00
|
,00
|
,00
|
46,00
|
,00
|
,00
|
,00
|
46,00
|
,00
|
,00
|
,00
|
43,00
|
,00
|
,00
|
,00
|
49,00
|
,00
|
,00
|
,00
|
7 Multiple Linear Regression
The interaction variable will be used
together with treatment modality and gender as independent
variables in a multiple linear regression model. For analysis the
statistical model Linear in the module Regression is
required.
Command:
-
Analyze….Regression….Linear….Dependent: PAF …Independent (s): treat, gender, interaction….click OK.
Coefficientsa
Model
|
Unstandardized coefficients
|
Standardized coefficients
|
t
|
Sig.
|
||
---|---|---|---|---|---|---|
B
|
Std. error
|
Beta
|
||||
1
|
(Constant)
|
46,400
|
1,084
|
42,795
|
,000
|
|
Treatment
|
−16,200
|
1,533
|
−1,224
|
−10,565
|
,000
|
|
Gender
|
−9,600
|
1,533
|
−,726
|
−6,261
|
,000
|
|
Interaction
|
17,200
|
2,168
|
1,126
|
7,932
|
,000
|
The above table shows the results of
the multiple linear regression. Like with fixed effect analysis of
variance, both treatment modality and interaction are statistically
significant. The t-value-interaction of the regression = 7,932. The
F-value-interaction of the fixed effect analysis of
variance = 62,916 and this equals 7,9322. Obviously, the
two approaches make use of a very similar arithmetic.
Unfortunately, for random effect
regression SPSS has limited possibilities.
8 Conclusion
Interaction is different from
confounding (Chap. 22). In a trial with interaction
effects the parallel group characteristics are equally distributed
between the groups. However, there are subsets of patients that
have an unusually high or low response to one of the treatments.
Assessments are reviewed.
9 Note
More background, theoretical, and
mathematical information of interaction assessments is given in
Statistics applied to clinical studies 5th edition, Chap. 30,
Springer Heidelberg Germany, 2012, from the same authors.